Related Articles
High farnesoid X receptor expression predicts favorable clinical outcomes in PD‑L1<sup>low/negative</sup> non‑small cell lung cancer patients receiving anti‑PD‑1‑based chemo‑immunotherapy
Anti‑VEGF antibody triggers the effect of anti‑PD‑L1 antibody in PD‑L1<sup>low</sup> and immune desert‑like mouse tumors
Prognosis value of circulating tumor cell PD‑L1 and baseline characteristics in patients with NSCLC treated with immune checkpoint inhibitors plus platinum‑containing drugs
Distribution characteristics and clinical significance of infiltrating T cells in the tumor microenvironment of pancreatic cancer
Expression of immune checkpoint PD‑1 in non‑small cell lung cancer is associated with tumor cell DNA‑dependent protein kinase